Gainers
- Calithera Biosciences CALA shares increased by 37.2% to $0.22 during Friday's pre-market session. The market value of their outstanding shares is at $24.7 million. The company's, Q1 earnings came out 3 days ago.
- PolarityTE PTE shares rose 35.15% to $0.2. The company's market cap stands at $17.7 million.
- Celularity CELU shares moved upwards by 25.47% to $7.24. The company's market cap stands at $997.0 million.
- Molecular Partners MOLN stock rose 19.47% to $7.26. The market value of their outstanding shares is at $234.4 million.
- Baudax Bio BXRX shares rose 19.45% to $1.19. The market value of their outstanding shares is at $7.6 million.
- Inotiv NOTV stock rose 17.05% to $14.0. The market value of their outstanding shares is at $356.4 million. As per the press release, Q2 earnings came out yesterday.
Losers
- FIGS FIGS stock decreased by 21.4% to $10.1 during Friday's pre-market session. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q1 earnings came out yesterday.
- Salarius Pharmaceuticals SLRX stock declined by 18.92% to $0.18. The market value of their outstanding shares is at $10.0 million. As per the news, the Q1 earnings report came out yesterday.
- Regulus Therapeutics RGLS stock fell 18.16% to $0.2. The market value of their outstanding shares is at $29.3 million. As per the press release, Q1 earnings came out yesterday.
- Ekso Bionics Holdings EKSO shares decreased by 11.46% to $1.48. The company's market cap stands at $18.9 million.
- Allakos ALLK stock fell 7.72% to $2.87. The company's market cap stands at $157.2 million.
- Brickell Biotech BBI stock decreased by 7.21% to $0.19. The market value of their outstanding shares is at $22.9 million. As per the press release, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in